The short version
Just 3 companies supply this market — thin enough that a single exit would be felt immediately.
Market view
14 marketed package NDCs · 3 active manufacturers
Most dispensed: 16.2 mg; .1037 mg; .0194 mg; .0065 mg · Tablet · #100 tablets/bottle, plastic · 16.2 mg/5mL; .1037 mg/5mL; .0194 mg/5mL; .0065 mg/5mL · Elixir · #118 mL/bottle · 16.2 mg/5mL; .1037 mg/5mL; .0194 mg/5mL; .0065 mg/5mL · Elixir · #473 mL/bottle
Just 3 companies supply this market — thin enough that a single exit would be felt immediately.
Every detected change for phenobarbital, hyoscyamine sulfate, atropine sulfate, scopolamine hydrobromide, newest first — price moves, shortages, recalls, and manufacturers entering or leaving. Detected by comparing each day’s federal data against the day before.
Other molecules FDA puts in Cholinergic Muscarinic Antagonist, with whether each is in shortage right now. Same class is not the same drug — substitution is a clinical decision, and this is a supply picture, not a recommendation.
Expand a strength to see its dosage forms, then package sizes, then each manufacturer and NDC. Click an NDC for its full detail page.